<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang F</submitter><funding>Shanghai Hospital Development Center</funding><pagination>e080541</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10961500</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(3)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Haemodialysis is the most common treatment option for patients with life-sustaining end-stage kidney disease (ESKD). In recent years, haemodiafiltration or haemofiltration has been widely used in patients with ESKD, and there are still conflicting findings as to whether both are superior to traditional haemodialysis. This systematic review and meta-analysis were designed to determine whether haemodiafiltration or haemofiltration is more effective than haemodialysis in reducing all-cause mortality risk in patients with ESKD.&lt;h4>Methods and analysis&lt;/h4>We will perform a systematic PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library and Scopus search, including studies published before September 2023. Randomised controlled tri</pubmed_abstract><journal>BMJ open</journal><pubmed_title>Effects of haemodiafiltration or haemofiltration compared with haemodialysis on prognosis in patients with end-stage renal disease: protocol an updated systematic review and meta-analysis of randomised trials with trial sequential analysis.</pubmed_title><pmcid>PMC10961500</pmcid><funding_grant_id>SHDC2022CRD003</funding_grant_id><pubmed_authors>Liao J</pubmed_authors><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Zhong Y</pubmed_authors><pubmed_authors>Bai Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of haemodiafiltration or haemofiltration compared with haemodialysis on prognosis in patients with end-stage renal disease: protocol an updated systematic review and meta-analysis of randomised trials with trial sequential analysis.</name><description>&lt;h4>Introduction&lt;/h4>Haemodialysis is the most common treatment option for patients with life-sustaining end-stage kidney disease (ESKD). In recent years, haemodiafiltration or haemofiltration has been widely used in patients with ESKD, and there are still conflicting findings as to whether both are superior to traditional haemodialysis. This systematic review and meta-analysis were designed to determine whether haemodiafiltration or haemofiltration is more effective than haemodialysis in reducing all-cause mortality risk in patients with ESKD.&lt;h4>Methods and analysis&lt;/h4>We will perform a systematic PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library and Scopus search, including studies published before September 2023. Randomised controlled tri</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-27T03:55:57.31Z</modification><creation>2025-04-06T19:01:15.918Z</creation></dates><accession>S-EPMC10961500</accession><cross_references><pubmed>38521518</pubmed><doi>10.1136/bmjopen-2023-080541</doi></cross_references></HashMap>